8,239 Shares in Chemed Corporation $CHE Acquired by Abacus FCF Advisors LLC

Key Points

• Abacus FCF Advisors acquired 8,239 Chemed shares worth approximately $3.84 million, while institutional investors collectively own 95.85% of the company.
• Chemed reported quarterly earnings of $6.06 per share, beating estimates of $5.60, with revenue up 8.8% year over year to $673.25 million. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Analysts maintain a predominantly cautious outlook, with one Buy rating and five Holds and a consensus price target of $530.75. Chemed also raised its quarterly dividend to $0.70 per share from $0.60.

Abacus FCF Advisors LLC acquired a new stake in shares of Chemed Corporation (NYSE:CHE - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 8,239 shares of the company's stock, valued at approximately $3,837,000. Abacus FCF Advisors LLC owned approximately 0.06% of Chemed at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Chemed by 2,444,879.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company's stock worth $2,374,667,000 after buying an additional 5,549,876 shares during the last quarter. BlackRock Inc. purchased a new stake in Chemed in the second quarter valued at $691,290,000. Norges Bank purchased a new stake in Chemed in the fourth quarter valued at $76,067,000. AQR Capital Management LLC grew its position in Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company's stock worth $139,302,000 after purchasing an additional 153,469 shares during the period. Finally, Victory Capital Management Inc. grew its position in Chemed by 1,260.2% during the 4th quarter. Victory Capital Management Inc. now owns 117,685 shares of the company's stock worth $50,353,000 after purchasing an additional 109,033 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Oppenheimer raised their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. Weiss Ratings raised Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Zacks Research raised shares of Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. Bank of America restated a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Wall Street Zen upgraded Chemed from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 1st. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Chemed has an average rating of "Hold" and a consensus target price of $530.75.

Insider Activity at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the company's stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 3,537 shares of company stock worth $1,782,654. Corporate insiders own 3.33% of the company's stock.

Chemed Stock Performance

Chemed stock opened at $535.86 on Thursday. The firm has a 50 day simple moving average of $494.52 and a 200-day simple moving average of $445.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The stock has a market cap of $7.00 billion, a price-to-earnings ratio of 26.91, a price-to-earnings-growth ratio of 2.00 and a beta of 0.51. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same quarter last year, the firm posted $4.27 earnings per share. Chemed's revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is a boost from Chemed's previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed's payout ratio is currently 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source